XML 42 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 23, 2014
Mar. 24, 2013
Cash flows from operating activities:    
Net income $ 40,474 $ 34,420
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,421 5,631
Gains on sale/disposal of assets (1,556) (88)
Amortization of deferred financing costs 1,390 1,431
Provision for deferred income taxes 700 4,568
Non-cash compensation expense 4,455 5,616
Tax impact from equity-based compensation (7,834) (2,574)
Other 45 (959)
Changes in operating assets and liabilities (7,891) (396)
Net cash provided by operating activities 36,204 47,649
Cash flows from investing activities:    
Capital expenditures (6,561) (5,086)
Proceeds from sale of assets 3,906 1,228
Changes in restricted cash 16,827 (1,360)
Other (279) 882
Net cash provided by (used in) investing activities 13,893 (4,336)
Cash flows from financing activities:    
Repayments of long-term debt and capital lease obligations (6,032) (6,170)
Proceeds from exercise of stock options 2,458 1,528
Tax impact from equity-based compensation 7,834 2,574
Purchases of common stock (15,131) (18,019)
Tax payments for restricted stock upon vesting (4,308) (2,656)
Payments of common stock dividends and equivalents (11,053) (327)
Net cash used in financing activities (26,232) (23,070)
Effect of exchange rate changes on cash and cash equivalents 128 25
Change in cash and cash equivalents 23,993 20,268
Cash and cash equivalents, at beginning of period 14,383 [1] 54,813
Cash and cash equivalents, at end of period $ 38,376 $ 75,081
[1] The balance sheet at December 29, 2013 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.